Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, shared a post on LinkedIn:
“Just published in Nature Reviews Disease Primers during EHA2026.
Chronic GvHD remains the leading cause of non-relapse mortality and one of the greatest unmet needs after allogeneic transplantation.
This comprehensive review captures where we stand today, and where the field is heading tomorrow: from disease biology and biomarkers to novel therapies and personalized care.
The mission is no longer just to help patients survive transplantation, but to help them live well after it.”
Title: Chronic graft-versus-host disease
Authors: Yishan Ye, Bipin Savani, Florent Malard, Annalisa Ruggeri, Imane Aboudale, Zinaida Peric, He Huang, Mohamad Mohty
Read the Full Article.
Other articles featuring Mohamad Mohty on OncoDaily.